Naresh Kumar

Naresh Kumar

Auto-generated profile, based on publicly available information

Naresh Kumar

Intermountain Medical Center, Salt Lake City, UT, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Annals of the American Thoracic Society
Verified
Journal Article
Open access
SBSamuel M. Brown
Samuel M. Brown
IPIthan D. Peltan
Ithan D. Peltan
BWBrandon Webb
Brandon Webb
NKNaresh Kumar
Naresh Kumar
NSNathan Starr
Nathan Starr
TGTom Greene
Tom Greene
Coronavirus disease (COVID-19) is a potentially fatal illness with no proven therapy beyond excellent supportive care. Treatments are urgently sought. Adaptations to traditional trial logistics and design to allow rapid implementation, evaluation of trials within a global trials context, flexible interim monitoring, and access outside traditional research hospitals (even in settings where formal placebos are unavailable) may be helpful. Thoughtful adaptations to traditional trial designs, especially within the global context of related studies, may also foster collaborative relationships among government, community, and the research enterprise. Here, we describe the protocol for a pragmatic, active comparator trial in as many as 300 patients comparing two current “off-label” treatments for COVID-19—hydroxychloroquine and azithromycin—in academic and nonacademic hospitals in Utah. We developed the trial in response to local pressures for widespread, indiscriminate off-label use of these medications. We used a hybrid Bayesian-frequentist design for interim monitoring to allow rapid, contextual assessment of the available evidence. We also developed an inference grid for interpreting the range of possible results from this trial within the context of parallel trials and prepared for a network meta-analysis of the resulting data. This trial was prospectively registered (ClinicalTrials.gov Identifier: NCT04329832) before enrollment of the first patient. Clinical trial registered with www.clinicaltrials.gov (NCT04329832).

10 May 2022 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
ASAllan M. Seibert
Allan M. Seibert
ESEdward Stenehjem
Edward Stenehjem
AWAnthony Wallin
Anthony Wallin
PWPark Willis
Park Willis
KBKim Brunisholz
Kim Brunisholz
AHAdam Hersh
Adam Hersh

1 May 2023
Verified
Conference Paper
Closed access
GHG. Hooper
G. Hooper
DGD.W. Guidry
D.W. Guidry
NKN. Kumar
N. Kumar
KBK. Brown
K. Brown
WBW. Beninati
W. Beninati
IPI.D. Peltan
I.D. Peltan